Soleus Capital Management, L.P.

Position in MIRM — Mirum Pharmaceuticals, Inc.

CIK 1802630 GREENWICH, CT

Position in MIRM

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$8,780,250

-$28,200,018 QoQ

Shares Held

75,000

-81.3% QoQ

Ownership

0.116%

of shares outstanding

% of Portfolio

0.30%

of 13F equity value

Holder Rank

#95

of 327 holders

Holding Since

Mar 2022

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Soleus Capital Management, L.P. holds $1,743,217,207 across 63 Biotechnology names. MIRM ranks #39 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KRYS	Krystal Biotech, Inc.	939,254	$349,092,534
2	CELC	Celcuity Inc.	1,704,318	$178,305,749
3	TGTX	Tg Therapeutics, Inc.	2,927,895	$160,858,551
4	RIGL	Rigel Pharmaceuticals Inc	1,843,504	$72,117,876
5	VCEL	Vericel Corp	1,459,152	$64,917,672
6	PRAX	Praxis Precision Medicines, Inc.	177,517	$59,430,916
7	GERN	Geron Corp	42,808,659	$54,795,083
8	ERAS	Erasca, Inc.	2,700,000	$49,464,000

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8,780,250	75,000	-81.3%	Shares	Sole	2026-08-11
2026-03-31	$36,980,268	400,306	-30.2%	Shares	Sole	2026-05-14
2025-12-31	$45,309,769	573,614	+285.8%	Shares	Sole	2026-02-12
2025-09-30	$10,900,903	148,696	-50.2%	Shares	Sole	2025-11-14
2025-06-30	$15,200,639	298,696	+190.0%	Shares	Sole	2025-08-15
2023-09-30	$3,254,800	103,000	-41.5%	Shares	Sole	2023-11-14
2023-06-30	$4,553,120	176,000	-27.3%	Shares	Sole	2023-08-14
2023-03-31	$5,812,840	242,000	+78.4%	Shares	Sole	2023-05-15
2022-09-30	$2,849,334	135,618	-30.8%	Shares	Sole	2022-11-14
2022-06-30	$3,814,510	196,018	-42.9%	Shares	Sole	2022-08-15
2022-03-31	$7,563,870	343,500	—	Shares	Sole	2022-05-16
No filing history on record for this holder in this stock.